Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

DDD100097 (Synonyms: DDD-100097, DDD 100097)

Catalog No. T23973 Copy Product Info
Purity: 99.93%
😃Good
DDD100097 is a potent N-myristoyltransferase inhibitor with potential inhibitory effects on Trypanosoma brucei, which can be used to study neurological disorders.

DDD100097

Copy Product Info
😃Good
Catalog No. T23973
Synonyms DDD-100097, DDD 100097

DDD100097 is a potent N-myristoyltransferase inhibitor with potential inhibitory effects on Trypanosoma brucei, which can be used to study neurological disorders.

DDD100097
Cas No. 1215012-74-0
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$210In StockIn Stock
5 mg$582In StockIn Stock
10 mg$720In StockIn Stock
25 mg$953In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.93%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

DDD100097 AI Summary
DDD100097 exhibits potent bioactivities in various assays. It shows high inhibitory activity against Trypanosoma brucei N-myristoyltransferase with an IC50 value of 2.0 nM and inhibits human N-myristoyltransferase 1 with an IC50 value of 12.0 nM. Demonstrating strong antitrypanosomal activity, it has an EC50 value of 1.0 nM against Trypanosoma brucei BSF427. However, its antiproliferative activity against human MRC5 cells is less pronounced, with an EC50 value of 1000.0 nM. The ratio of drug level in the brain to blood in wild-type NMRI mice is 1.6. The compound has a maximum tolerated dose of 100.0 mg/kg when administered orally twice daily to mice. Its intrinsic clearance in CD1 mouse liver microsomes is 2.5 mL·min-1·g-1. Additionally, it shows inhibitory activity against human ERG with an IC50 value of 600.0 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
DDD100097 is a potent N-myristoyltransferase inhibitor with potential inhibitory effects on Trypanosoma brucei, which can be used to study neurological disorders.
SynonymsDDD-100097, DDD 100097
Chemical Properties
Molecular Weight523.47
FormulaC22H30Cl2F2N4O2S
Cas No.1215012-74-0
SmilesN(S(=O)(=O)C1=C(Cl)C=C(CCCC2CCN(C)CC2)C=C1Cl)(C(F)F)C3=C(C)N(C)N=C3C
Relative Density.1.31g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 7.5 mg/mL (14.33 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9103 mL9.5516 mL19.1033 mL95.5165 mL
5 mM0.3821 mL1.9103 mL3.8207 mL19.1033 mL
10 mM0.1910 mL0.9552 mL1.9103 mL9.5516 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy DDD100097 | purchase DDD100097 | DDD100097 cost | order DDD100097 | DDD100097 chemical structure | DDD100097 formula | DDD100097 molecular weight